M Ventures

Investing in transformational ideas

€600m Fund allocation

2009 Inception of M Ventures

90+ Total investments

Entrepreneurs at heart in Biotechnology and Technology

M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. We cover the areas of Healthcare drug development, Life Science tools, Electronics and Frontier Technology & Sustainability.

We invest - with dual strategic and financial foci - into visionary companies that find new ways to: treat the most challenging diseases, empower scientists with cutting-edge research and development tools, develop new solutions that change the way in which information is accessed, stored, processed, and displayed and address some of the most complex challenges in sustainability and technology convergence.

We take an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success.

Alain Vicari, CEO

Calypso Biotech is an immunotherapy biotech company, spin-off from Merck KGaA, Darmstadt, Germany, that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs.

Peretz Partensky, CEO / Jesse Cotari, CSO

ImmuneBridge is amplifying nature's innate intelligence to develop allogeneic immunotherapies for cancer.

Jon Herlocker, CEO

Tignis combines the precise insights of physics with the most advanced AI and ML data science to give semiconductor equipment manufacturers, wafer fabs, and components and materials suppliers unprecedented automation and process control.

Jan Blochwitz-Nimoth, CEO

Solving the holy grail of OLED research: an efficient AND stable, deep-blue emitter for next gen OLED displays

Dr. Wei Lu, CTO

MemryX is a fabless semiconductor company that designs and sells innovative Edge AI processors

Tony Johnson, Chairman of the Board

Outrun Therapeutics is an E3 ligase inhibitor company leveraging its activity-based probe as a platform to discover and develop novel therapeutics for cancer and other relevant diseases.

Ramses Alcaide, CEO

At Neurable, we’re translating brain activity into simple, actionable insights you can use in your everyday life. After all, your brain knows you best.

Rob Devlin, Co-founder and CEO

Metalenz is a fabless semiconductor optics company on a mission to revolutionize optical sensing with metasurface technology.

Latest News

All Portfolio News